Moreover, its expression also exhibits prognostic significance in multiple myeloma, enabling the better risk stratification of stage II myeloma patients [23], underscoring the translational value of circ-CCT3 for precision oncology in solid and hematological malignancies. The gene discussed is CCT3; the disease is AL amyloidosis.